H2 receptor antagonists vs placebo or no prophylaxis
ICU mortality · people admitted to intensive care units
H2 receptor antagonists showed no clear difference in all‐cause mortality in ICU compared with placebo or no prophylaxis (low certainty).
1 finding from 1 review
- Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes onlyRR 1.12 [0.88, 1.42]14 studies · 1428 participantsLow